BIOLOGICAL ACTIONS OF 1,25 (OH) 2D3

Information

  • Research Project
  • 3464341
  • ApplicationId
    3464341
  • Core Project Number
    R29DK043267
  • Full Project Number
    5R29DK043267-04
  • Serial Number
    43267
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/1992 - 32 years ago
  • Project End Date
    11/30/1993 - 31 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1993 - 31 years ago
  • Budget End Date
    11/30/1993 - 31 years ago
  • Fiscal Year
    1993
  • Support Year
    4
  • Suffix
  • Award Notice Date
    8/31/1993 - 31 years ago

BIOLOGICAL ACTIONS OF 1,25 (OH) 2D3

Vitamin D has diverse and pleiotropic biological effects. Classically it has been considered to be one of the key regulators of calcium and phosphorous homeostasis in the body. More recently, however, non classical roles as an immunomodulator and regulator of cellular proliferation have become more apparent. Associated with these functions are numerous diseases where alterations of the vitamin D pathway have been implicated. Clearly determination of action of vitamin D will allow elucidation of its role in osteogenesis, odontogenesis, and ultimately lead to advances in the treatment of osteoporosis, osteomalacia and other related disease states. The recent cloning of the vitamin D receptor and comparison of its primary sequence with that of other cloned steroid receptors have indicated clearly that the vitamin D receptor is closely related to the receptors of other steroid hormones. The subsequent development of a vitamin D responsive transcription unit in heterologous cells and the use of reverse genetics has allowed an elucidation of the functional domains of the receptor. More structural information was obtained from studies which identified the molecular defects in receptors isolated from patients with type II vitamin D dependent rickets. However, a more comprehensive analysis of receptor structure and a microdissection of functional domains is required and can best be accomplished by a combined biochemical and genetics approach. In order to advance further our understanding of the mechanism of action of vitamin D receptor, we propose to exploit a new novel eucaryotic host system for studies of vitamin D receptor action. This non-mammalian system (Saccharomyces cerevisiae) will allow us to probe 3 areas of vitamin D action: (A) Receptor structure: Genetic screens will be used to determine the critical amino acids required for ligand binding. (B) The mechanism of activation of transcription: utilizing genetic screens to identify factors other than the receptor required for activation of transcription. (C) Studies of the role of phosphorylation on receptor function. Because of the similarity in the mechanisms of all the steroid receptors, any information gained in this study will advance the knowledge in steroid hormone action as a whole. Furthermore, elucidation of the structures required for hormone binding will complement structural analysis of the molecule which together will ultimately lead to a rational drug design program for vitamin D agonists and antagonists.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R29
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    GMB
  • Study Section Name
    General Medicine B Study Section
  • Organization Name
    LIGAND PHARMACEUTICALS
  • Organization Department
  • Organization DUNS
  • Organization City
    CRANBURY
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    08512
  • Organization District
    UNITED STATES